Baker McKenzie advised the syndicate of 10 underwriters on the deal. Teva Pharmaceutical Industries Limited executed a multi-tranche USD 2.5 billion (equivalent) (upsized from USD 2.06 billion)...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here